Found: 12
Select item for more details and to access through your institution.
New Variants in the Enpp1 and Ptpn6 Genes Cause Low BMD, Crystal-Related Arthropathy, and Vascular Calcification.
- Published in:
- Journal of Bone & Mineral Research, 2009, v. 24, n. 9, p. 1552, doi. 10.1359/JBMR.090417
- By:
- Publication type:
- Article
Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis.
- Published in:
- Journal of Bone & Mineral Research, 2009, v. 24, n. 4, p. 578, doi. 10.1359/jbmr.081206
- By:
- Publication type:
- Article
Denosumab, a Fully Human Monoclonal Antibody to RANKL, Inhibits Bone Resorption and Increases BMD in Knock-In Mice That Express Chimeric (Murine/Human) RANKL.
- Published in:
- Journal of Bone & Mineral Research, 2009, v. 24, n. 2, p. 182, doi. 10.1359/jbmr.081112
- By:
- Publication type:
- Article
Targeted Deletion of the Sclerostin Gene in Mice Results in Increased Bone Formation and Bone Strength.
- Published in:
- Journal of Bone & Mineral Research, 2008, v. 23, n. 6, p. 860, doi. 10.1359/jbmr.080216
- By:
- Publication type:
- Article
Infrequent Delivery of a Long-Acting PTH-Fc Fusion Protein Has Potent Anabolic Effects on Cortical and Cancellous Bone.
- Published in:
- Journal of Bone & Mineral Research, 2007, v. 22, n. 10, p. 1534, doi. 10.1359/JBMR.070616
- By:
- Publication type:
- Article
Sustained Antiresorptive Effects After a Single Treatment With Human Recombinant Osteoprotegerin (OPG): A Pharmacodynamic and Pharmacokinetic Analysis in Rats.
- Published in:
- Journal of Bone & Mineral Research, 2003, v. 18, n. 5, p. 852, doi. 10.1359/jbmr.2003.18.5.852
- By:
- Publication type:
- Article
A Chimeric Form of Osteoprotegerin Inhibits Hypercalcemia and Bone Resorption Induced by IL-1β, TNF-α, PTH, PTHrP, and 1,25(OH)<sub>2</sub>D<sub>3</sub>.
- Published in:
- Journal of Bone & Mineral Research, 1999, v. 14, n. 9, p. 1478, doi. 10.1359/jbmr.1999.14.9.1478
- By:
- Publication type:
- Article
Inhibition of RANKL blocks skeletal tumor progression and improves survival in a mouse model of breast cancer bone metastasis.
- Published in:
- Clinical & Experimental Metastasis, 2008, v. 25, n. 2, p. 119, doi. 10.1007/s10585-007-9127-1
- By:
- Publication type:
- Article
Bone Metastasis: Can osteoclasts be excluded? (Reply).
- Published in:
- 2007
- By:
- Publication type:
- Letter
Regulation of cancer cell migration and bone metastasis by RANKL.
- Published in:
- Nature, 2006, v. 440, n. 7084, p. 692, doi. 10.1038/nature04524
- By:
- Publication type:
- Article
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.
- Published in:
- Nature, 1999, v. 402, n. 6763, p. 43, doi. 10.1038/35005552
- By:
- Publication type:
- Article
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis.
- Published in:
- Nature, 1999, v. 397, n. 6717, p. 315, doi. 10.1038/16852
- By:
- Publication type:
- Article